| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Magnesium hydrate |
Is a |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Polyamine methylene resin |
Is a |
True |
Antacid (substance) |
Inferred relationship |
Some |
|
| calciumantacidum |
Is a |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Magnesium oxide |
Is a |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Aluminiumbaseret antacidum |
Is a |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Disodium citrate (substance) |
Is a |
True |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing calcium acetate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Antacid adverse reaction |
Causative agent |
True |
Antacid (substance) |
Inferred relationship |
Some |
1 |
| Magnesium trisilicate adverse reaction |
Causative agent |
False |
Antacid (substance) |
Inferred relationship |
Some |
2 |
| Aluminum hydroxide adverse reaction |
Causative agent |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| allergi over for antacid |
Causative agent |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Allergy to magnesium trisilicate |
Causative agent |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Allergy to aluminium hydroxide (finding) |
Causative agent |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| overdosis af antacidum |
Causative agent |
False |
Antacid (substance) |
Inferred relationship |
Some |
1 |
| Aluminum hydroxide overdose |
Causative agent |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Accidental aluminium hydroxide overdose |
Causative agent |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Intentional aluminum hydroxide overdose |
Causative agent |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| overdosis af aluminiumhydroxid, uvist med hvilken hensigt |
Causative agent |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Magnesium trisilicate overdose (disorder) |
Causative agent |
False |
Antacid (substance) |
Inferred relationship |
Some |
2 |
| Accidental magnesium trisilicate overdose |
Causative agent |
False |
Antacid (substance) |
Inferred relationship |
Some |
2 |
| Intentional magnesium trisilicate overdose |
Causative agent |
False |
Antacid (substance) |
Inferred relationship |
Some |
2 |
| overdosis af magnesiumtrisilicat, uvist med hvilken hensigt |
Causative agent |
False |
Antacid (substance) |
Inferred relationship |
Some |
2 |
| Official/simple antacids |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Aluminum hydroxide [antacid] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Aluminium hydroxide 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Aluminum hydroxide oral suspension BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing precisely aluminium hydroxide 475 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Magnesium salts-antacid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Sodium bicarbonate [antacid] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Compound antacids |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Generic antacids |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Aluminium hydroxide 600 mg and magnesium hydroxide 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Dried aluminium hydroxide gel 44 mg/mL and magnesium hydroxide 39 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Dried aluminium hydroxide gel 120 mg/mL and magnesium hydroxide 60 mg/mL oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| antacider indeholdende calcium/bismuth |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| calciumcarbonatforbindelse som pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| kridt, pædiatrisk mikstur |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing chalk (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| aromatisk kridt, pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| aromatisk kridt + opiummikstur |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Calcium carbonate 1.25 g chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing precisely calcium carbonate 1.5 gram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing precisely calcium carbonate 2.5 gram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Calcium carbonate 1.25 g effervescent oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing precisely calcium carbonate 1.25 gram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing precisely calcium carbonate 2.5 gram/1 sachet granules for conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| calciumglubion + calciumlactobion 1,09 g/723 mg/5 ml syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| calciumforbindelse 400 mg brusetablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| calciumforbindelse 1000 mg brusetablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Aluminum hydroxide [nutritional use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Calcium carbonate 420 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Calcium acetate 1 g oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| antacida som kun indeholder aluminium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| antacida indeholdende aluminium og magnesium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| antacidapræparater, mærkevarer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Co-magaldrox product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| flydende antacidum |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| antacidumtablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| antacidumpulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Co-simalcite |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Calcium og magnesium-produkt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| kombinationsprodukt med calcium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing precisely calcium acetate 667 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Calcium acetate 333.5 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| magnesiumbaseret antacidum |
Is a |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Alginic acid |
Is a |
True |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing calcium carbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| antacid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing aluminium hydroxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| aluminiumhydroxid + belladonna som mikstur |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| aluminiumhydroxid + belladonna |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| natriumalginat 500 mg/5 ml + kaliumhydrogencarbonat 100 mg/5 ml sukkerfri oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| natriumalginat 225 mg/dosis + magnesiumalginat 87,5 mg/dosis, sukkerfrit oralt pulver i brev |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| dimeticon 125 mg + hydrotalcit 500 mg sukkerfri oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Calcium carbonate 1.25 g and colecalciferol 5 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Calcium electrolyte 1.25 g and colecalciferol 10 microgram chewable tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| calciumcarbonat 1,25 g + cholecalciferol 11 µg brev granulat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing precisely calcium carbonate 1.5 gram and colecalciferol 10 microgram/1 each conventional release chewable tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| kaolin 500 mg + calciumcarbonat 250 mg/5 ml børnesuspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to alexitol sodium |
Causative agent |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to magnesium carbonate |
Causative agent |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Adverse reaction caused by hydrotalcite (disorder) |
Causative agent |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to magaldrate |
Causative agent |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to sodium bicarbonate |
Causative agent |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to antacids and antigastric secretion drugs NOS |
Causative agent |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing magnesium malate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing precisely magnesium malate 250 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| dinatriumetidronat 400 mg tablet og calciumcarbonat 1,25 g brusetabletpakke |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing bismuth subsalicylate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing bismuth subsalicylate and metronidazole and tetracycline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| dinatriumetidronat + calciumcarbonat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing bismuth (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Co-simalcite suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| sæt indeholdende bismuthsubsalicylat 262,4 mg + metronidazol 250 mg + tetracyclinhydrochlorid 500 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Aluminium compound |
Is a |
True |
Antacid (substance) |
Inferred relationship |
Some |
|
| Bismuth compound |
Is a |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Sodium bicarbonate (substance) |
Is a |
True |
Antacid (substance) |
Inferred relationship |
Some |
|
| Magnesium carbonate (substance) |
Is a |
True |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing sodium alginate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing calcium carbonate and simeticone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
| Product containing calcium glubionate and calcium lactobionate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Antacid (substance) |
Inferred relationship |
Some |
|
FHIR